These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17941341)

  • 1. Longitudinal trajectories of cognitive change in preclinical Alzheimer's disease: a growth mixture modeling analysis.
    Small BJ; Bäckman L
    Cortex; 2007 Oct; 43(7):826-34. PubMed ID: 17941341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of cognitive change from preclinical to clinical Alzheimer's disease.
    Jones S; Small BJ; Fratiglioni L; Backman L
    Brain Cogn; 2002 Jul; 49(2):210-3. PubMed ID: 15259392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preclinical phase in vascular dementia: cognitive impairment three years before diagnosis.
    Jones S; Laukka EJ; Small BJ; Fratiglioni L; Bäckman L
    Dement Geriatr Cogn Disord; 2004; 18(3-4):233-9. PubMed ID: 15286452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
    Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
    Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive deficits in preclinical Alzheimer's disease and vascular dementia: patterns of findings from the Kungsholmen Project.
    Bäckman L; Small BJ
    Physiol Behav; 2007 Sep; 92(1-2):80-6. PubMed ID: 17573076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical AD predicts decline in memory and executive functions in subjective complaints.
    van Harten AC; Smits LL; Teunissen CE; Visser PJ; Koene T; Blankenstein MA; Scheltens P; van der Flier WM
    Neurology; 2013 Oct; 81(16):1409-16. PubMed ID: 24049134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Longitudinal Study of the Mini-Mental State Examination in Late Nonagenarians and Its Relationship with Dementia, Mortality, and Education.
    Skoog J; Backman K; Ribbe M; Falk H; Gudmundsson P; Thorvaldsson V; Borjesson-Hanson A; Ostling S; Johansson B; Skoog I
    J Am Geriatr Soc; 2017 Jun; 65(6):1296-1300. PubMed ID: 28323333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring cognitive change in a cohort of patients with Alzheimer's disease.
    Galasko DR; Gould RL; Abramson IS; Salmon DP
    Stat Med; 2000 Jun 15-30; 19(11-12):1421-32. PubMed ID: 10844707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinction between preclinical Alzheimer's disease and depression.
    Visser PJ; Verhey FR; Ponds RW; Kester A; Jolles J
    J Am Geriatr Soc; 2000 May; 48(5):479-84. PubMed ID: 10811539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.
    Suh GH; Ju YS; Yeon BK; Shah A
    Int J Geriatr Psychiatry; 2004 Sep; 19(9):817-24. PubMed ID: 15352138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline.
    Hochstetler H; Trzepacz PT; Wang S; Yu P; Case M; Henley DB; Degenhardt E; Leoutsakos JM; Lyketsos CG
    J Alzheimers Dis; 2016; 50(1):271-82. PubMed ID: 26639960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease.
    Olichney JM; Galasko D; Salmon DP; Hofstetter CR; Hansen LA; Katzman R; Thal LJ
    Neurology; 1998 Aug; 51(2):351-7. PubMed ID: 9710002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing cognitive changes in the elderly: reliable change indices for the Mini-Mental State Examination.
    Stein J; Luppa M; Maier W; Wagner M; Wolfsgruber S; Scherer M; Köhler M; Eisele M; Weyerer S; Werle J; Bickel H; Mösch E; Wiese B; Prokein J; Pentzek M; Fuchs A; Leicht H; König HH; Riedel-Heller SG;
    Acta Psychiatr Scand; 2012 Sep; 126(3):208-18. PubMed ID: 22375927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive Change at the End of Life in Nursing Home Residents: Differential Trajectories of Terminal Decline.
    Hülür G; Wolf H; Riese F; Theill N
    Gerontology; 2019; 65(1):57-67. PubMed ID: 30041168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of preclinical Alzheimer's disease in a clinical setting.
    Visser PJ; Verhey FR; Ponds RW; Jolles J
    Int Psychogeriatr; 2001 Dec; 13(4):411-23. PubMed ID: 12003248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study.
    Galvin JE; Powlishta KK; Wilkins K; McKeel DW; Xiong C; Grant E; Storandt M; Morris JC
    Arch Neurol; 2005 May; 62(5):758-65. PubMed ID: 15883263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample.
    Small BJ; Fratiglioni L; Viitanen M; Winblad B; Bäckman L
    Arch Neurol; 2000 Jun; 57(6):839-44. PubMed ID: 10867781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early symptoms and signs of cognitive deficits might not always be detectable in persons who develop Alzheimer's disease.
    Palmer K; Bäckman L; Winblad B; Fratiglioni L
    Int Psychogeriatr; 2008 Apr; 20(2):252-8. PubMed ID: 18257960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate of cognitive decline in preclinical Alzheimer's disease: the role of comorbidity.
    Bäckman L; Jones S; Small BJ; Agüero-Torres H; Fratiglioni L
    J Gerontol B Psychol Sci Soc Sci; 2003 Jul; 58(4):P228-36. PubMed ID: 12878651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mini-Mental State Examination item scores as predictors of Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm.
    Small BJ; Viitanen M; Bäckman L
    J Gerontol A Biol Sci Med Sci; 1997 Sep; 52(5):M299-304. PubMed ID: 9310084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.